SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001585364-22-000008
Filing Date
2022-03-01
Accepted
2022-03-01 07:13:51
Documents
14
Period of Report
2022-03-01
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K prgo-20220301.htm   iXBRL 8-K 57604
2 EX-99.1 cy21q4ex991pressrelease.htm EX-99.1 916995
6 perrigoimagenewa.jpg GRAPHIC 18151
  Complete submission text file 0001585364-22-000008.txt   1196992

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT prgo-20220301.xsd EX-101.SCH 1912
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT prgo-20220301_lab.xml EX-101.LAB 24906
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT prgo-20220301_pre.xml EX-101.PRE 13193
8 EXTRACTED XBRL INSTANCE DOCUMENT prgo-20220301_htm.xml XML 10793
Mailing Address 515 EASTERN AVENUE ALLEGAN MI 49010
Business Address THE SHARP BUILDING HOGAN PLACE DUBLIN 2 L2 D02 TY74 269-673-8451
PERRIGO Co plc (Filer) CIK: 0001585364 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36353 | Film No.: 22693925
SIC: 2834 Pharmaceutical Preparations